Marx-Gross, Susanne http://orcid.org/0000-0003-1831-0210
Fieß, Achim
Münzel, Thomas
Wild, Philipp Sebastian
Beutel, Manfred Elmar
Schmidtmann, Irene
Lackner, Karl Johannes
Pfeiffer, Norbert
Schuster, Alexander Karl-Georg
Funding for this research was provided by:
Government of Rhineland-Palatinate
Johannes Gutenberg-Universität Mainz
Boehringer Ingelheim
Boehringer Ingelheim
PHILIPS Medical Systems
BFederal Ministry of Education and Research (BMBF 01EO1503)
DIASyM research core (BMBF 161L0219)
German Center for Cardiovascular Research
Philips Medical Systems
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Article History
Received: 21 February 2023
Revised: 19 May 2023
Accepted: 26 May 2023
First Online: 14 June 2023
Declarations
: The study was presented as FR10-01 on 30.09.2022 at 120. Congress DOG, Berlin, Germany.
: All procedures performed in studies involving were in accordance with the ethical standards of the ethics committee of the Medical Chamber of Rhineland-Palatinate, Mainz, Germany and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all study participants prior to their study entry and the GHS complies with Good Clinical Practice (GCP), Good Epidemiological Practice (GEP). The study protocol and study documents were approved by the ethics committee of the Medical Chamber of Rhineland-Palatinate, Mainz, Germany (reference no. 837.020.07; original vote: 22.3.2007, latest update: 20.10.2015).
: All authors: There are no conflicts of interest reported regarding this work. The Gutenberg Health Study is funded through the Government of Rhineland-Palatinate (“Stiftung Rheinland-Pfalz für Innovation,” contract AZ 961–386261/733), the research programs “Wissen schafft Zukunft” and “Center for Translational Vascular Biology (CTVB)” of the Johannes Gutenberg-University of Mainz, and its contract with Boehringer Ingelheim and PHILIPS Medical Systems, including an unrestricted grant for the Gutenberg Health Study.SMG: outside the submitted work, she reports grants from Bayer AG.AS is supported by the Intramural Research Funding (Stufe I) of the University Medical Center of Johannes Gutenberg University Mainz and the Ernst- und Berta-Grimmke Stiftung and the Else Kröner-Fresenius-Stiftung.TM is PI of the German Center for Cardiovascular Research (DZHK), outside this he has no relevant financial or non-financial interests to disclose. Wild PS is funded by the Federal Ministry of Education and Research (BMBF 01EO1503) and he and Münzel T are PI of the German Center for Cardiovascular Research (DZHK). Wild PS is principal investigator of the DIASyM research core (BMBF 161L0219).PSW: Outside the submitted work, PSW reports grants from Bayer AG, non-financial grants from Philips Medical Systems, grants and consulting fees from Boehringer Ingelheim, grants and consulting fees from Novartis Pharma, grants and consulting fees from Sanofi-Aventis, grants, consulting and lecturing fees from Bayer Health Care, grants and consulting fees from Daiichi Sankyo Europe, lecturing fees from Pfizer Pharma, lecturing fees from Bristol Myers Squibb, consulting fees from Astra Zeneca, consulting fees and non-financial support from Diasorin and non-financial support from IEM. PSW is funded by the European Regional Development Fund and the Ministry of Science and Health of the State of Rhineland-Palatinate (EFRE/REACT-EU, Grant No. 84007232 and No. 84009735), the Federal Ministry of Education and Research (BMBF 01EO1503, 81Z0210103, 81Z0210102, 03ZU1202AA, 03ZU1202CD, 03ZU1202DB, 03ZU1202JC, 03ZU1202KB, 03ZU1202LB, 03ZU1202MB, 03ZU1202OA), Ministry of Science and Health of the State of Rhineland Palatinate (MWG RLP 724–0010#2021/0030–1501), the ReALity Initiative of the Life Sciences of the Johannes Gutenberg University Mainz for the establishment of a cell bank, the National Research Network University Medicine on Covid-19 (”NaFoUniMedCovid19″, Grant No. 01KX2021) B-FAST, and the Federal Institute for Occupational Safety and Health (BAuA, F2447 / 537727) outside the present work. PSW is principal investigator of the German Center for Cardiovascular Research (DZHK) and principal investigator of the DIASyM research core (BMBF DIASyM research core (BMBF 161L0217A, 031L0217A).MB has no relevant financial or non-financial interests to disclose.IS has no relevant financial or non-financial interests to disclose.KL has no relevant financial or non-financial interests to disclose.NP has no relevant financial or non-financial interests to disclose.AKS: There are no conflicts of interest reported regarding this work. Outside the submitted work, AKS reports grants from Bayer, Novartis and Santen, grants and consulting fees from Abbvie and Apells, non-financial grants from Heidelberg Engineering.